Global X Funds - Global X Genomics & Biotechnology ETF
GNOM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.86B
Close$
$13.15
81.1% downside
Current Fair Value
81.1% downsideOvervalued by 81.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $13.86 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.65 |
| Dividend yield | 0.93% |
| Earnings per Share | $- |
| Beta | 1.6 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.28%▼ 27.63% |
|---|---|
| Total Invested | $5.43M▼ 80.18% |
| Investors Holding | 15▼ 35.00% |
About Global X Funds
The Global X MSCI Colombia ETF (COLO) aims to replicate the financial performance, encompassing both capital appreciation and dividend income, of the MSCI All Colombia Select 25/50 Index, before factoring in any fund-related fees and expenses.